“COMPARATIVE STUDY OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY TERRITORIAL DISTRIBUTION AND ITS IMPROVEMENT (A CASE STUDY OF ANDIJAN REGION)”

Authors

  • Yusupova Shahnoza Qodirjonovna,Juliyeva Yulduz Gayrat kizi Scientific Supervisor,Assistant, Department of Hospital Therapy and Endocrinology

Keywords:

Type 2 diabetes mellitus, treatment adherence, patient compliance, regional analysis, territorial differences, Andijan region, glycemic control, diabetes complications, healthcare accessibility, rural health, patient education, chronic disease management.

Abstract

Type 2 diabetes mellitus is one of the most important chronic non-communicable diseases and remains a serious medical and social problem due to its high prevalence, long-term complications, and the need for lifelong treatment. One of the main conditions for effective diabetes management is treatment adherence, which includes regular medication intake, compliance with dietary recommendations, physical activity, self-monitoring, and timely follow-up visits. The aim of this study was to comparatively assess treatment adherence among patients with type 2 diabetes mellitus across different territorial units of Andijan region and to develop proposals for its improvement. A cross-sectional comparative study was conducted among adult patients with confirmed type 2 diabetes mellitus receiving follow-up care in healthcare institutions of Andijan region. Data were collected using patient interviews, structured questionnaires, and medical record review. Adherence levels were evaluated according to medication-taking behavior, lifestyle compliance, and regularity of medical follow-up. Comparative and statistical analyses were performed to determine regional differences and factors associated with poor adherence. The study showed significant territorial differences in treatment adherence. Higher adherence was observed among patients living in urban areas, while lower adherence was more common in rural and remote districts. Poor adherence was associated with low educational level, insufficient family support, longer disease duration, presence of complications, irregular medical supervision, and limited access to healthcare services. In contrast, regular counseling, better healthcare accessibility, and stronger family support had a positive effect on adherence. The findings indicate that treatment adherence among patients with type 2 diabetes mellitus is influenced by a combination of medical, social, and organizational factors. Comparative regional assessment makes it possible to identify local barriers to effective diabetes management and to develop targeted measures aimed at improving adherence. Strengthening diabetes education, expanding access to healthcare in rural areas, and improving continuity of follow-up may contribute to better clinical outcomes and reduction of diabetes-related complications in Andijan region.

References

International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.

World Health Organization. Global report on diabetes. Geneva: WHO; 2016.

American Diabetes Association. Standards of care in diabetes—2024. Diabetes Care. 2024;47(Suppl. 1):S1–S350.

Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the ADA and the EASD. Diabetes Care. 2022;45(11):2753–2786.

Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.

Capoccia K, Odegard PS, Letassy N. Medication adherence with diabetes medication: a systematic review of the literature. Diabetes Educ. 2016;42(1):34–71.

Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes. Diabetes Care. 2017;40(11):1588–1596.

Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159.

Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12:14.

Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9.

Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35(6):1239–1245.

Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviors and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med. 2012;29(5):682–689.

Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–737.

Sabaté E, ed. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.

Simmons D, Hartnell S, Morrison B, et al. Effectiveness of diabetes education and support interventions. BMC Endocr Disord. 2015;15:46.

Nguyen TMU, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? Patient Prefer Adherence. 2014;8:353–363.

Kleinsinger F. The unmet challenge of medication nonadherence. Perm J. 2018;22:18–033.

Downloads

Published

2026-04-21

How to Cite

Yusupova Shahnoza Qodirjonovna,Juliyeva Yulduz Gayrat kizi. (2026). “COMPARATIVE STUDY OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY TERRITORIAL DISTRIBUTION AND ITS IMPROVEMENT (A CASE STUDY OF ANDIJAN REGION)”. Ethiopian International Journal of Multidisciplinary Research, 13(4), 1717–1725. Retrieved from https://www.eijmr.org/index.php/eijmr/article/view/6290